Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39799 Certara, Inc. (Exact name of registrant as specified in its charter) Delaware 82-2180925 (State or other ...

Certara, Inc. (NASDAQ:CERT) Q1 2021 Earnings Conference Call May 6, 2021 5:00 PM ET Company Participants David Deuchler - Investor Relations William Feehery - Chief Executive Officer Andrew Schemick - Chief Financial Officer Conference Call Participants Luke Sergott - Barclays Dave Windley - Jefferies Michael Ryskin - Bank of America John Kreger - William Blair Operator Good day and thank you for standing by. Welcome to the Certara First Quarter 2021 First Quarter 2021 Earnings Conference Call. At this time ...

Accelerating Medicines First Quarter 2021 Financial Results May 6, 2021 Disclaimer Numerical figures in the presentation have been subject to rounding adjustments. Accordingly, numerical figures shown as totals in various tables may not be arithmetic aggregations of the figures that precede them. Trademarks and Service Marks The Certara design logo, "Certara," and our other registered or common law trademarks, service marks or trade names appearing in this presentation are our property. Solely for convenien ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39799 Certara, Inc. (Exact name of registrant as specified in its charter) Delaware 82-2180925 (State or othe ...

Accelerating Medicines March 2021 Disclaimer . The following presentation has been prepared by Certara, Inc. ("we", "us", or "the Company") solely for informational purposes and should not be construed to be, directly or indirectly, in whole or in part, an offer to buy or sell and/or an invitation and/or a recommendation and/or a solicitation of an offer to buy or sell any security or instrument or to participate in any investment or trading strategy, nor shall any part of it form the basis of, or be relied ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____to _____ Commission File Number: 001-39799 Certara, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 82-2180925 (State o ...

Accelerating Medicines 4Q 2020 and FY 2020 Financial Results March 4, 2021 Disclaimer Numerical figures in the presentation have been subject to rounding adjustments. Accordingly, numerical figures shown as totals in various tables may not be arithmetic aggregations of the figures that precede them. Trademarks and Service Marks The Certara design logo, "Certara," and our other registered or common law trademarks, service marks or trade names appearing in this presentation are our property. Solely for conven ...

Certara, Inc. (NASDAQ:CERT) Q4 2020 Earnings Conference Call March 4, 2021 5:00 PM ET Company Participants David Deuchler - IR William Feehery - Chief Executive Officer Andrew Schemick - Chief Financial Officer Conference Call Participants Vikram Purohit - Morgan Stanley Michael Ryskin - Bank of America David Windley - Jefferies Erin Wright - Credit Suisse John Kreger - William Blair Luke Sergott - Barclays Operator Ladies and gentlemen, thank you for standing by and welcome to the Certara Fourth Quarter 20 ...